[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351950-105":59,"doc-detail-351950-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ai-in-esophageal-cancer-advances-barriers-to-clinical-translation-and-perspectives-for-digital-health","AI in esophageal cancer - advances, barriers to clinical translation, and perspectives for digital health","","Esophageal cancer (EC) remains a leading cause of cancer-related mortality worldwide, making accurate staging, treatment planning, and prognostic assessment essential for better clinical outcomes. Recent advances in artificial intelligence (AI) leverage clinicopathological, imaging, and genomic data to support diagnosis, treatment-response prediction, and risk stratification. This review summarizes AI progress in EC, addresses barriers limiting clinical translation, and outlines future directions for research and digital health implementation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ai-in-esophageal-cancer-advances-barriers-to-clinical-translation-and-perspectives-for-digital-health/351950/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ai-in-esophageal-cancer-advances-barriers-to-clinical-translation-and-perspectives-for-digital-health/351950.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is AI considered promising for esophageal cancer management?","Question",{"text":112,"@type":113},"Because AI methods can integrate clinical, imaging, and genomic information to support real-time diagnosis and prediction of treatment response, improving decision-making across multiple care stages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What key challenges limit AI’s clinical translation in esophageal cancer?",{"text":117,"@type":113},"The review highlights difficulties that require more precise strategies for early detection, monitoring treatment response, and enhancing prognostic assessment, alongside barriers that prevent widespread clinical implementation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which esophageal cancer subtypes are discussed and how do they differ?",{"text":121,"@type":113},"The document describes esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). Their distribution varies by geography, and these differences influence how disease is approached clinically.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351950,1790363038,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Yang et al. Journal of Translational Medicine (2026) 24:863  \n[https://doi.org/10.1186/s12967-026-08270-3](https://doi.org/10.1186/s12967-026-08270-3)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nAI in esophageal cancer: advances, barriers to clinical translation, and perspectives for digital health  \nYuqi Yang1, Xiao Jia2, Xi Wang3, Pingdong Cao1, Jian Zhu4, Chuanxi Wang1, Zhe Yang1 and Qiang Wen1*  \nAbstract  \nBackground Esophageal cancer (EC) remains one of the leading causes of cancer-related mortality worldwide. Accurate staging, treatment planning, and prognostic assessment are essential for improving clinical management and patient outcomes. In recent years, artificial intelligence (AI) approaches integrating clinicopathological, imaging, and genomic data have shown considerable potential in these areas.  \nMain body Over the past two years, research in this field has advanced rapidly, supported by the growing availability of large datasets and increasing adoption of multicenter external validation. Recent studies suggest that AI can improve real-time diagnosis and enhance the prediction of treatment response in patients with EC.  \nConclusions This review summarizes recent advances in AI applications for esophageal cancer, discusses current challenges, and highlights future directions for research and clinical implementation.  \nKeywords Esophageal cancer, Artificial intelligence, Deep learning, Machine learning, Prognosis  \nIntroduction  \nEsophageal cancer (EC) remains a major cause of cancer-related morbidity and mortality worldwide, largely because it is often diagnosed at an advanced stage and is associated with aggressive biological behavior [1]. Esophageal squamous cell carcinoma (ESCC) and esophageal  \n*Correspondence:  \nQiangWen  \n[wq890425@126.com](wq890425@126.com)  \n1Department of Radiation Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong First Medical University, 324 Jingwu Road, Jinan, Shandong 250021, China  \n2School of Control Science and Engineering, Shandong University, Jinan, China  \n3Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA  \n4Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250021, China  \nadenocarcinoma (EAC) are the two major histological subtypes, and their distribution varies markedly across geographic regions. ESCC predominates in Asia, whereas EAC is more prevalent in Europe and the Americas [2]. Treatment selection in EC is strongly stage dependent. In early-stage disease, endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) can be curative in carefully selected patients [3]. For locally advanced disease, treatment depends on tumor location and extent and often includes esophagectomy, concurrent chemoradiotherapy, or a combination of both. Advanced or metastatic disease requires comprehensive multidisciplinary evaluation to individualize systemic therapy. Because of substantial heterogeneity in histopathology, tumor biology, and treatment approaches, clinical outcomes and therapeutic responses vary considerably across patients [4]. These challenges highlight the need for more precise  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indic","cbCaiofMvHrtPZFc","https://ap.wps.com/l/cbCaiofMvHrtPZFc","pdf",2379043,"English","# Abstract\n## Background\n## Main body\n## Conclusions\n# Introduction\n## Disease burden and clinical challenges\n## Histological subtypes and stage-dependent treatment\n## Need for more precise strategies\n# AI Foundations and Clinical Applications\n## AI, machine learning, and deep learning\n## Uses across diagnosis and treatment evaluation\n## Gap in existing reviews","[{\"question\":\"Why is AI considered promising for esophageal cancer management?\",\"answer\":\"Because AI methods can integrate clinical, imaging, and genomic information to support real-time diagnosis and prediction of treatment response, improving decision-making across multiple care stages.\"},{\"question\":\"What key challenges limit AI’s clinical translation in esophageal cancer?\",\"answer\":\"The review highlights difficulties that require more precise strategies for early detection, monitoring treatment response, and enhancing prognostic assessment, alongside barriers that prevent widespread clinical implementation.\"},{\"question\":\"Which esophageal cancer subtypes are discussed and how do they differ?\",\"answer\":\"The document describes esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). Their distribution varies by geography, and these differences influence how disease is approached clinically.\"}]","AI in esophageal cancer - advances, barriers to clinical translation, and perspectives for digital health | PDF",1790096586,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffb5e3a5260ba1eaab4184ff9edcf248.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b3e742483dd3c3dfec0732b0e719d9d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e53c31da86bb88b7043d81f8fc55b528.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c04bb33ac56dcb22a4134b84effa3d6.webp",980,1306]